17 October 17
LeenLife Pharma International:
- Production and Operations in North America
- Exclusivity Agreement with BioCubeTM
"October 17, 2017 CSE - LLP
The Company is pleased to announce it has entered into an exclusive agreement with BioCube Corporation Ltd. (“BioCube”), an Australian company with offices in British Columbia, to purchase equipment to manufacture the Company’s Omega 3 products based on flax seed oil.
BioCube, offers LeenLife Pharma a on or off-grid platform that provides seamless integration into the commercial production process of LeenLife Pharma’s proprietary and industry leading Omega-3 formulations."
Read the full announcement here
Find out more about BioCube here